Vasan RS - Search Results

1

Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.

Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, Griffin G, Guerin C, Ho JE, Shaw SY, Cohen KS, Vasan RS, Tedgui A, Boulanger CM, Wang TJ. Amabile N, et al. Among authors: vasan rs. Eur Heart J. 2014 Nov 7;35(42):2972-9. doi: 10.1093/eurheartj/ehu153. Epub 2014 Apr 16. Eur Heart J. 2014. PMID: 24742886 Free PMC article.

2

Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study.

Vasan RS, Massaro JM, Wilson PW, Seshadri S, Wolf PA, Levy D, D'Agostino RB; Framingham Heart Study. Vasan RS, et al. Circulation. 2002 Jan 1;105(1):48-53. doi: 10.1161/hc0102.101774. Circulation. 2002. PMID: 11772875

3

Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study.

Walsh CR, Larson MG, Evans JC, Djousse L, Ellison RC, Vasan RS, Levy D. Walsh CR, et al. Among authors: vasan rs. Ann Intern Med. 2002 Feb 5;136(3):181-91. doi: 10.7326/0003-4819-136-3-200202050-00005. Ann Intern Med. 2002. PMID: 11827493

4

Serum potassium is not associated with blood pressure tracking in the Framingham Heart Study.

Walsh CR, Larson MG, Vasan RS, Levy D. Walsh CR, et al. Among authors: vasan rs. Am J Hypertens. 2002 Feb;15(2 Pt 1):130-6. doi: 10.1016/s0895-7061(01)02293-2. Am J Hypertens. 2002. PMID: 11863248

5

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Vasan RS, et al. JAMA. 2002 Feb 27;287(8):1003-10. doi: 10.1001/jama.287.8.1003. JAMA. 2002. PMID: 11866648

6

Serum potassium and risk of cardiovascular disease: the Framingham heart study.

Walsh CR, Larson MG, Leip EP, Vasan RS, Levy D. Walsh CR, et al. Among authors: vasan rs. Arch Intern Med. 2002 May 13;162(9):1007-12. doi: 10.1001/archinte.162.9.1007. Arch Intern Med. 2002. PMID: 11996610

7

Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS. Wang TJ, et al. Among authors: vasan rs. Am J Cardiol. 2002 Aug 1;90(3):254-8. doi: 10.1016/s0002-9149(02)02464-5. Am J Cardiol. 2002. PMID: 12127613

8

Obesity and the risk of heart failure.

Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Kenchaiah S, et al. Among authors: vasan rs. N Engl J Med. 2002 Aug 1;347(5):305-13. doi: 10.1056/NEJMoa020245. N Engl J Med. 2002. PMID: 12151467 Free article.

9

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, Levy D. Vasan RS, et al. JAMA. 2002 Sep 11;288(10):1252-9. doi: 10.1001/jama.288.10.1252. JAMA. 2002. PMID: 12215132

10

Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (The Framingham Heart Study).

Morshedi-Meibodi A, Larson MG, Levy D, O'Donnell CJ, Vasan RS. Morshedi-Meibodi A, et al. Among authors: vasan rs. Am J Cardiol. 2002 Oct 15;90(8):848-52. doi: 10.1016/s0002-9149(02)02706-6. Am J Cardiol. 2002. PMID: 12372572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,200 results

Search Page

Filters